Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review
Applied Health Economics and Health Policy · 2026-01 · 24 (1) · 147-161
DOI: 10.1007/s40258-025-01006-2 ↗Kurz gefasst
Scoping Review in der Zeitschrift Applied Health Economics and Health Policy, online erschienen am 23.09.2025. Verfasst von Patricia Vester und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Christoph-Probst-Weg 3, …. Hauptthemen laut MEDLINE: Cost of Illness, Fatigue Syndrome, Chronic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Academic Research Foundation (DFG),, Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
OBJECTIVE: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious chronic and complex multi-system disease characterised by symptoms such as post-exertional malaise, fatigue, cognitive impairment and pain. Diagnosis is based on international consensus criteria, and no curative treatment is available. In the USA, its prevalence is estimated at 0.42% among adults, with women affected three times as often as men. Prevalence is expected to increase due to the COVID-19 pandemic. In addition to its severe symptoms, ME/CFS has a substantial economic impact. This scoping review aimed to systematically examine the global health, social and economic burden of ME/CFS. METHODS: We conducted a systematic literature search following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) guidelines in six databases and supplemented it with a citation search. We assessed study quality using a modified version of the Mixed Methods Appraisal Tool. RESULTS: We included 20 studies that assessed costs (n = 16), disability-adjusted life years (DALYs) (n = 3), employment rates (n = 1), and school attendance (n = 1) as indicators of disease burden. Reported costs per patient ranged from USD 2,916 to USD 119,611, with indirect costs accounting for the largest proportion. DALYs reported for the USA ranged from 0.714 million in 2016 to 5.77 million in 2022. CONCLUSION: ME/CFS imposes a substantial health, social and economic burden of disease. Discrepancies in estimates are probably due to differences in study samples, methodologies, cost components, and healthcare systems. Because ME/CFS is assumed to be underdiagnosed, its true burden may be even higher.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Christoph-Probst-Weg 3, 20251, Hamburg, Germany. p.vester@uke.de.
- Hamburg Center for Health Economics (HCHE), University of Hamburg, Hamburg, Germany. p.vester@uke.de.
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Christoph-Probst-Weg 3, 20251, Hamburg, Germany.
- Hamburg Center for Health Economics (HCHE), University of Hamburg, Hamburg, Germany.
Förderung
- German Academic Research Foundation (DFG),
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Vester, P., Boudouroglou-Walter, S., Schreyögg, J., Wieting, C., & Blome, C. (2026). Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review. Applied Health Economics and Health Policy, 24(1), 147-161. https://doi.org/10.1007/s40258-025-01006-2
Vancouver
Vester P, Boudouroglou-Walter S, Schreyögg J, Wieting C, Blome C. Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review. Applied Health Economics and Health Policy. 2026;24(1):147-161. doi:10.1007/s40258-025-01006-2
BibTeX
@article{Vester2026,
author = {Vester, Patricia and Boudouroglou-Walter, Stefanos and Schreyögg, Jonas and Wieting, Chantal and Blome, Christine},
title = {Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review},
journal = {Applied Health Economics and Health Policy},
year = {2026},
volume = {24},
number = {1},
pages = {147--161},
doi = {10.1007/s40258-025-01006-2}
}
EUVIMED